Literature DB >> 9177239

Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance.

I Gloaguen1, P Costa, A Demartis, D Lazzaro, A Di Marco, R Graziani, G Paonessa, F Chen, C I Rosenblum, L H Van der Ploeg, R Cortese, G Ciliberto, R Laufer.   

Abstract

Receptor subunits for the neurocytokine ciliary neurotrophic factor (CNTF) share sequence similarity with the receptor for leptin, an adipocyte-derived cytokine involved in body weight homeostasis. We report here that CNTF and leptin activate a similar pattern of STAT factors in neuronal cells, and that mRNAs for CNTF receptor subunits, similarly to the mRNA of leptin receptor, are localized in mouse hypothalamic nuclei involved in the regulation of energy balance. Systemic administration of CNTF or leptin led to rapid induction of the tis-11 primary response gene in the arcuate nucleus, suggesting that both cytokines can signal to hypothalamic satiety centers. Consistent with this idea, CNTF treatment of ob/ob mice, which lack functional leptin, was found to reduce the adiposity, hyperphagia, and hyperinsulinemia associated with leptin deficiency. Unlike leptin, CNTF also reduced obesity-related phenotypes in db/db mice, which lack functional leptin receptor, and in mice with diet-induced obesity, which are partially resistant to the actions of leptin. The identification of a cytokine-mediated anti-obesity mechanism that acts independently of the leptin system may help to develop strategies for the treatment of obesity associated with leptin resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177239      PMCID: PMC21071          DOI: 10.1073/pnas.94.12.6456

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Immortalized young adult neurons from the septal region: generation and characterization.

Authors:  H J Lee; D N Hammond; T H Large; B H Wainer
Journal:  Brain Res Dev Brain Res       Date:  1990-03-01

2.  The influence of genetic background on the expression of the obese (Ob) gene in the mouse.

Authors:  D L Coleman; K P Hummel
Journal:  Diabetologia       Date:  1973-08       Impact factor: 10.122

3.  Studies with the mutation, diabetes, in the mouse.

Authors:  D L Coleman; K P Hummel
Journal:  Diabetologia       Date:  1967-04       Impact factor: 10.122

Review 4.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

Authors:  C Schindler; J E Darnell
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

5.  Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake.

Authors:  W Langhans; R Harlacher; G Balkowski; E Scharrer
Journal:  Physiol Behav       Date:  1990-05

6.  Dietary obesity in nine inbred mouse strains.

Authors:  D B West; C N Boozer; D L Moody; R L Atkinson
Journal:  Am J Physiol       Date:  1992-06

7.  The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter.

Authors:  B J Wagner; T E Hayes; C J Hoban; B H Cochran
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

8.  The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development.

Authors:  N Y Ip; J McClain; N X Barrezueta; T H Aldrich; L Pan; Y Li; S J Wiegand; B Friedman; S Davis; G D Yancopoulos
Journal:  Neuron       Date:  1993-01       Impact factor: 17.173

9.  The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat.

Authors:  B C Varnum; Q F Ma; T H Chi; B Fletcher; H R Herschman
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain.

Authors:  D Lazzaro; M Price; M de Felice; R Di Lauro
Journal:  Development       Date:  1991-12       Impact factor: 6.868

View more
  39 in total

1.  Circumventing leptin resistance for weight control.

Authors:  S P Kalra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 4.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

5.  Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults.

Authors:  Carole Escartin; Karin Pierre; Angélique Colin; Emmanuel Brouillet; Thierry Delzescaux; Martine Guillermier; Marc Dhenain; Nicole Déglon; Philippe Hantraye; Luc Pellerin; Gilles Bonvento
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

6.  Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes.

Authors:  Ursula A White; William C Stewart; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

7.  Induction of leptin resistance by activation of cAMP-Epac signaling.

Authors:  Makoto Fukuda; Kevin W Williams; Laurent Gautron; Joel K Elmquist
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

Review 8.  Peptides and their potential role in the treatment of diabetes and obesity.

Authors:  Hannah C Greenwood; Stephen R Bloom; Kevin G Murphy
Journal:  Rev Diabet Stud       Date:  2011-11-10

9.  The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR).

Authors:  Eva-Maria Wagener; Matthias Aurich; Samadhi Aparicio-Siegmund; Doreen M Floss; Christoph Garbers; Kati Breusing; Björn Rabe; Ralf Schwanbeck; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

10.  Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Authors:  David Sanchez-Infantes; Ursula A White; Carrie M Elks; Ron F Morrison; Jeffrey M Gimble; Robert V Considine; Anthony W Ferrante; Eric Ravussin; Jacqueline M Stephens
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.